secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001493152-25-028019
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics opens affiliated sleep center in Auburn Hills, Michigan under MISleep Solutions agreement
--------------------------------------------------------------------------------

- Grand opening of sleep testing and treatment center near Detroit in Auburn Hills, MI on Dec 16, 2025.
- Center operates under July 2025 agreement with MISleep Solutions, LLC for management/support services.
- Model is capital-efficient contractual alliance, distinct from outright acquisition; follows summer 2025 acquisition of The Sleep Center of Nevada.
- Vivos brings FDA-cleared diagnostic and therapeutic products for obstructive sleep apnea (OSA) to the center.
- Company is in talks with other sleep center groups across the U.S. for similar affiliations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315225028019/0001493152-25-028019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315225028019/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer